Clinical Trial: A Study Testing the Safety and Effects of FB102 in Healthy Volunteers

U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623057) titled 'A Study Testing the Safety and Effects of FB102 in Healthy Volunteers' on May 28.

Brief Summary: The purpose of this Phase 1 trial is to evaluate the safety and effects of FB-102 in healthy volunteers following single and multiple doses.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: FB102 Single dose

FB102 will be administered as a single dose

DRUG: FB102 Multiple doses

FB102 will be administered once weekly for 4 doses.

DRUG: FB102 Placebo

Matching placebo identical to FB102 formulation but without the active pharmaceutical ingredient

Recruitment Status: NOT_YET_...